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ABSTRACT 
Background; Evidence suggests that caudate nucleus abnormalities have a role in 
schizophrenia. Structural brain imaging studies on caudate size in schizophrenia are 
inconclusive due to confounding factors. 
Methods: In this study, caudate volume was measured on coronal Magnetic Resonance 
Images (I -mm) in consenting 15 never-treated schizophrenia (DSM-IV) patients and 
15 age, sex, handedness, education and socioeconomic status matched controls 
using semi-automated Scion image software. 
Results: Multivariate analysis revealed significantly smaller caudate volume in patients 
than controls after controlling for intracranial area (df = 2,27; F = 5.4; p = 0.028). 
Separate univariate analysis showed that right (df = 2,27; F = 5.4; p = 0.028) and 
left (df = 2,27; F = 5.2; p = 0.031) caudate were significantly smaller in patients than 
controls after controlling for intracranial area. Illness duration did not correlate 
significantly with either right (r = - 0.13; p = 0.65) or left (r = - 0.10; p = 0.7) 
caudate volume. 
Discussion: Significantly smaller caudate nucleus in patients with never-treated 
schizophrenia suggests that some aspect of the disease process of schizophrenia 
influences the caudate nucleus. In conclusion, smaller caudate volume in never-
treated schizophrenia with lack of correlation between illness duration and caudate 
size supports neurodevelopmental etiopathogenesis in schizophrenia. 
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INTRODUCTION 
Several lines of evidence implicate the 
basal ganglia in the pathophysiology of 
schizophrenia (Busatto and Kerwin, 1997; 
Ring and Serra-Mestres, 2W2). Basal ganglia 
play a critical role in higher cognitive func-
tions such as attention, working memory, 
and goal-directed behavior (Middleton and 
Strick 1994; Levy et al 1997; Graybtel 1997). 
Abnormalities of basal ganglia in disorders 
such as Huntington's chorea may result in 
disturbances in thinking and behavior remi-
niscent of schizophrenia (Heckers 1997). 
Involuntary movements were described in 
schizophrenia long before the era of 
neuroleptics (Kraepelin 1919); unusual 
movements are also seen in preschizophrenic 
children long before illness onset (Walker 
and Lewin 1990). 
Magnetic Resonance Imaging (MRI) al-
lows noninvasive in vivo examination of the 
structural abnormalities of the basal ganglia. 
Several MRI studies of the basal ganglia 
have appeared in the literature with conflict-
ing results (Shenton et al 1997). Studies 
have reported either increased volume of 
one or other basal ganglia structures (Breier 
et al 1992; DeLisi et al 1991; Hokama et 
al 1995; Frazier et al 1996) or no differences 
in basal ganglia size (Corey-Bloom et al 
1995; Kelsoe et al 1988; Flaum et al 1995). 
Studies have also shown a reduction in 
caudate size in schizophrenia patients (Mion 
et al 1991; Dalgalarrondo et al 1994; Young 
et al 1991; Brown et al 1996). These 
inconsistencies may be related to methodo-
logical issues, e.g., use of thick slices with 
interslice gaps, making it difficult to avoid 
partial volume effects. Further, most of 
these studies involved previously treated 
schizophrenic patients, which suggests that 
the observed changes may be related to 
neuroleptic treatment. 
Of the few studies comparing caudate 
volumes in neurolepric-naiVe schizophrenia 
patients and controls subjects, three studies 
have reported the caudate nucleus to be 
significantly smaller in patients (Shihabuddin 
et al 1998; Keshavan et al 1998; Corson et 
al 1999) and two studies have found no 
differences (Chakos et al 1994; Gur et al 
1998). In the only Indian study, caudate 
nucleus volume did not differ significantly 
between patients and controls (McCreadie 
et al 2002). 
Our study attempted to examine whether 
there is an independent underlying struc-
tural abnormality of caudate nucleus in 
never-treated schizophrenia. 
MATERIALS AND METHODS 
Subjects 
The subjects for the study consisted of 
fifteen patients and fifteen age, sex, educa-
tion, handedness and socioeconomic status 
matched healthy controls. The patients 
were recruited from National Institute of 
Mental Health and Neurosciences 
(NIMHANS) outpatient department if they 
met DSM-IV criteria for schizophrenia and 
had never received antipsychotic medication 
or electro convulsive therapy. The Sched-
ules for Clinical Assessment in Neuropsy-
chiatry (SCAN) (Version 2.1) (World Health 
Organization, 1998) was administered (GVS) 
for the diagnosis of patients. (The first 
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author (GVS) underwent training program 
for administering SCAN before starting the 
stud)-). This diagnosis was re-confirmed by 
consensus following independent clinical 
interview by two experienced psychiatrists 
(BNG & NJR). The diagnosis was found 
to be stable at one-year follow-up as re-
assessed by one of these two experienced 
psychiatrists (BNG or NJR). Psychopathol-
ogy was assessed by the Positive and Negative 
Syndrome Scale (PANSS) for schizophrenia 
(Kay et al., 1987). 
Hospital staff members, their relatives 
and friends formed the control group. The 
controls were selected after screening using 
GHQ (12 items version) (Goldberg et al 
1997). A detailed history was taken to rule 
out psychosis in any of the family members. 
None of the normal controls had any family 
history of psychotic illness. Normal con-
trols, as a group, were matched with die 
schizophrenia patients for age, sex, 
handedness, number of years of education 
and parental socioeconomic status. 
The demographic and clinical informa-
tion regarding the subjects were collected 
with the help of a structured proforma. A 
detailed history was obtained and a com-
prehensive mental state and physical exami-
nation was conducted. All subjects were 
right-handed as assessed by Annert's ques-
tionnaire (Annett, 1967). No subject had 
any contraindications to MRI (cardiac 
pacemaker, aneurysm clip, cochlear implants, 
pregnancy, IUD, history of metal fragment 
in eyes, neurostimulators, weight of 250 lbs. 
or more, claustrophobia). None of the 
subjects had any medical illness that may 
significantly influence CNS function or 
structure, significant neurologic disorder such 
as seizure disorder, cerebral palsy, or history 
suggestive of delayed developmental mile-
stones (suggestive of mental retardation), 
family history of hereditary neurologic dis-
order that may complicate diagnosis, life-
time co-morbidity for DSM-IV psychoactive 
substance dependence, or lifetime history of 
head injury associated with any of the 
following: loss of consciousness longer than 
10 minutes, seizures, neurological deficit, 
depressed skull fracture, surgical interven-
tion, or central nervous system infection. 
Female subjects were neither pregnant nor 
were within the postpartum period. None 
of the subjects had dyskinesia (as assessed 
using the Abnormal Involuntary Move-
ments Scale (Guy, 1976)) or parkinsonism 
(as assessed using the Simpson and Angus 
Scale (Simpson and Angus, 1970). All 






Magnetic Resonance Imaging (MRI) was 
done with Siemens 1.5 Tesla Magnetom 
vision system (Erlangen, Germany) at the 
Department of Neuroimaging and Inter-
ventional Radiology, NIMHANS. 
The list of MR protocols used in die 
study was: Proton Density (PD) & T2 
weighted transverse images; T2 weighted 
coronal images; and T Magnetization Pre-
pared Rapid Acquisition Gradient Echo 
(MP-RAGE) sequence. 
A set of sagittal scout images (2D fast 
spin echo, TR=15 msec, echo time fTE) 
= 6 msec, FOV = 300 mm, approximately 
3 slices, slice thickness = 8 mm, slice gap 
= 0.2 mm, NEX = 1, matrix = 256 x 256, 
scan time = 10 sec) was collected. 
This was followed by a set of proton 
density and T2 weighted axial images cov-
ering the whole brain (2D fast echo, TR = 
3800 msec, TE = 22 msec and 90 msec, 
FOV = 250 mm approximately 21 slices, 
slice thickness = 5 mm, slice gap = 0.3 mm, 
NEX = 1, matrix = 200 x 256, scan time 
2 min 5 sec). 
This was followed by a set of proton 
density and T2 weighted coronal images 
covering the whole brain (2D fast echo, TR 
= 3710 msec, TE = 22 msec and 90 msec, 
FOV = 230 mm approximately 21 slices, 
slice thickness = 5 mm, slice gap = 0.3 mm, 
NEX = 1, matrix = 190 x 256, scan time 
2 min 24 sec). 
Then, T, weighted three-dimensional 
Magnetization Prepared Rapid Acquisition 
Gradient Echo (MP-RAGE) imaging was 
performed in the sagittal plane. (TR = 9.7 
msec, TE = 4 msec, nutation angle = 12°, 
FOV = 250 mm, slice thickness 1 mm, 
NEX = 1, matrix = 200 x 256, scan time 
6 min 12 sec). A set of 160 images 
(approximately) covering die entire brain 
was obtained. 
MR images were examined by a 
neuroradiologist (PNJ) for morphological 
abnormalities blind to the status of subjects. 
The images were transferred on to a per-
sonal computer (PC) platform. They were 
stored with coded identification. 
VOLUMETRIC ANALYSIS 
SOFTWARE FOR MRI IMAGE 
ANALYSIS 
Volumetric measurements were conducted 
blind to clinical data using Scion Image 
software. It runs on PC and Macintosh 
platforms. Measurements can be stored 
separately from images. This software 
provides valid and reliable measurements of 
specific structures using a semi automated 
segmentation approach (Keshavan et al 1995). 
This semi automated segmentation method 
to measure volume of brain structures 
correlated highly with the point-counting 
stereological approach as tested by Keshavan 
et al 1995. This software has been used 
reliably to measure different brain structures 
and volumes in children, adolescents, and 
adults. The functions of this software 
include segmentation, magnification and 
contrast adjustment, data smoothening and 
orientation & location recall. 
VOLUMETRIC METHOD 
All measurements were automatically 
calculated by the computer using the Scion 
Image software. The desired structure was 
outlined and measured by the rater using 
the computer mouse controlled pointer. The 
raters were blind to the subjects' clinical 
details at the time of the brain measure-
ments on coded MRI sections. 
MEASUREMENT OF THE 
CAUDATE NUCLEUS 
The caudate nucleus was measured in 
coronal sections of MRI scan. The first 
step in measuring the caudate was to define 
the inferior border. The inferior border of 
the caudate was demarcated by drawing a 
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line along the length of the anterior com-
missure. The anterior commissure is a thin, 
reasonably straight line of white matter that 
will appear inferior to the lateral ventricles 
at about the point at which the fornix is 
first seen. The line was extended to be 
placed directly underneath the lateral ven-
tricles to eliminate the tail of the caudate 
from the measurement. The first slice was 
the most anterior slice where a small patch 
of grey matter appears laterally to either the 
left or right lateral ventricle. The rater 
continued to trace around the caudate in 
successive slices posteriorly through the 
brain, being careful not to extend the 
outline beyond the line used as the inferior 
border. The posterior limit of the caudate 
was defined as the first slice at which the 
pons is seen. 
The first author (GVS) who was initially 
trained by the neuroradiologist (PNJ) to 
measure the caudate performed inter-rater 
reliability exercise with another rater in 10 
subjects on coded images. The Inter-rater 
reliability as measured by Intra-Class Cor-
relation Coefficient was 0.94 for the left 





The intracranial area was measured in the 
mid-sagittal section. From the set of T, 
weighted three-dimensional MP-RAGE sag-
ittal images, the midsagittal section was 
chosen manually. Criteria (Woodruff et al 
1993) for the inclusion of midsagittal slices 
include the following: 
1. A distinct outline of the CC 
2. An easily identified cerebral aqueduct 
3. Clear visibility of cortical gyral crests 
both anteriorly and posteriorly to the 
CC and 
4. Absence of visible intrusion into gray 
and white matter. 
All the selected images were inspected 
and approved by the neuroradiologist (PNJ). 
Since the slice thickness was 1 mm and 
uniform image acquisition software protocol 
was used, midsagittal images of all the 
subjects satisfied the inclusion criteria. 
Intracranial area was measured by tracing 
along inner table of the skull, above the 
sphenoid sinus, along the basisphenoid, and 
across the foramen magnum (Keshavan et 
al 2002). 
To assess inter-rater reliability, two raters 
(GVS & PNJ (neuroradiologist)) independ-
endy rated sixteen coded midsagittal sec-
tions. The rater (GVS) was trained initially 
by the neuroradiologist (PNJ). Both the 
raters were blind to the clinical details of 
the subjects. 
The inter-rater reliability was calculated 
by intraclass correlation coefficient (ICQ. 
The intraclass correlation coefficient for the 
intracranial area was 0.95. 
STATISTICAL TECHNIQUES 
Statistical Package for Social Sciences 
(version - 10.0.1) was used for Pearson's 
correlation, Independent samples t-test, chi-
square test, Analysis of Covariance 
(ANCOVA), Repeated Measures Multivariate 
Analysis of Variance (RM - MANOVA). 
The alpha was set at 0.05 for statistical 
significance. 
RESULTS 
Demographic and clinical: 
The sociodemographic profile and cau-
date volume of the patients and controls 
is given in table 1. The average illness 
duration of the patients was 48 months 
TABLE I : Demographic Profile 
(range: 6 — 144 months). The Positive And 
Negative Syndrome Scale (PANSS) Scores 
(Mean ± SD) were as follows: Positive 
syndrome = 24±9; Negative syndrome = 
27±8; General psychopathology = 44±7; 
Total PANSS score = 95±13. 
BRAIN MORPHOMETRY 
Intracranial area (Mean ± SD) did not 
differ significandy between patients (127±11 
cm
2) and controls (127±13 cm
2) as tested 
by independent samples t-test (t = -0.06; p 
= 0.95). The mean (± SD) of the caudate 
volumes are given in table 2. Repeated 
Measures Analysis of Variance (RMANOVA) 
using the right and left caudate nuclei 
volumes as die repeated measures and the 
intracranial area as covariate showed signifi-
cant effect of the diagnosis with die patients 
having smaller right and left caudate vol-
umes dian the controls (df = 2,27; F = 5.4; 
p = 0.028). To analyze the effect of 
diagnosis on individual caudate volumes, 
univariate analysis of variance with intrac-
ranial area as covariate (ANCOVA) was 
performed separately for the right and left 
caudate volumes. Mean right and left 
caudate volumes were significandy smaller 
in the patients than the controls (table 2 & 
figure). 
Correlation of Caudate Volume with 
Illness duration and psychopathology 
Illness duration did not correlate signifi-
candy with either right caudate volume (r 
= - 0.13; p = 0.65) or left caudate volume 
(r = - 0.10; p = 0.7). No significant 
correlation was found between caudate 
volume and PANSS scores (positive syn-
drome, negative syndrome, general psycho-
pathology and total scores). 





Sex (M: F) 
Education (Years)** 
31 + 11 
7: 8 
11+4 
30 ± 9 
8: 7 
13 ± 2 
* No significant difference between patient and control groups 
** p<0.05, significant 
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TABLE 2 : Brain measure comparison 
Brain Structure  Patient (n= 15) Controls (n= 15) df F* p* 
Right Caudate (mL) 2.3 ± 0.6 
Left Caudate (mL) 2.3 ± 0.6 
Intracranial Area (sq.cm) 12.2 ±1.7 
2.7 ± 0.6 
2.8 ± 0.6 










* - Analysis of Covariance with Intracranial Area as covariate 
** - p < 0.05, significant. 
RIGHT AND LEFT CAUDATE VOLUMES 
































Right Caudate  Left Caudate 
Error Plot comparing the right and left caudate volumes of the patients and controls. 
* - Mean ± 2 Standard Error of the caudate volume 
DISCUSSION 
This study has demonstrated significandy 
smaller caudate nucleus volume in patients 
with never-treated schizophrenia in com-
parison to age, sex, education and 
handedness matched controls. Our find-
ings, together with those of Keshavan et al 
(1998), Shihabuddin et al (1998) and Corson 
et al (1999) support the notion that some 
aspect of the disease process of schizophre-
nia influences the caudate nucleus. The 
average volume reduction (16%) in our 
study is almost similar to one of the earlier 
studies (which demonstrated 14% volume 
reduction) by Keshavan et al (1998). To 
our knowledge, this is the first Indian study 
to demonstrate a reduction in caudate 
nucleus volume in never-treated schizophre-
nia. The only other Indian study by 
McCreadie et al (2002) did not show any 
difference in caudate volume between pa-
tients and controls. 
The Schedules for Clinical Assessment in 
Neuropsychiatry (Version 2.1) was used 
(GVS) for arriving at DSM-IV diagnosis. 
This diagnosis was also confirmed by con-
sensus following independent clinical inter-
view by two experienced psychiatrists (BNG 
& NJR). The diagnosis was found to be 
stable at follow-up after one year. None 
had a change in the diagnosis. Only few 
of the previous studies have reported about 
the stability of diagnosis. Subjects were 
excluded if they had substance dependence, 
confounding medical illness and lifetime 
history of significant head injury. Preg-
nancy or postpartum period also was one 
of the exclusion criteria. Thus the effect 
of confounding factors was minimized. 
All patients were treatment-naive. Medi-
cations were started only after completion 
of all assessments and investigations. This 
was done with informed consent. Many 
volumetric studies of the striatum in schizo-
phrenia have found enlargement of the 
striatal regions (Breier et al 1992; Buchanan 
et al 1993; Heckers et al 1991; Hokama et 
al 1995; Jernigan et al 1991; Swayze et al 
1992). Evidence suggests that this enlarge-
ment is a consequence of neuroleptic treat-
ment. Studies by Chakos et al (1994), 
Keshavan et al (1994), Elkashef et al (1994), 
Rodriguez et al (1997) and Gur et al (1998) 
noted that the increase in caudate volume 
in schizophrenia patients followed treatment 
with typical neuroleptics. Following the 
introduction of atypical neuroleptics, several 
follow-up studies noted a decrease in vol-
ume when patients were switched from 
typical to atypical neuroleptics (Chakos et 
al 1995; Frazier et al 1996; Westermoreland 
et al 1999). Assessing never-treated schizo-
phrenia patients avoided the confounding 
effect of neuroleptics. 
The caudate nuclei exhibit hemispheric 
lateralization with the right caudate being 
larger than the left caudate (Watkins et al 
2001). Thus handedness may be a factor 
influencing the structure and function of 
caudate. In this study, handedness was 
assessed using Annett's Handedness Ques-
tionnaire (Annett, 1967) and all subjects 
were right handed in this study. This helped 
in avoiding the confounding effect of 
handedness. 
Magnetic Resonance Imaging (MRI) was 
done using state-of-the-art Siemens 1.5 Tesla 
scanner. The stronger the magnet used for 
imaging the better will be the image reso-
lution (Filipek et al 1989). Two of the 
earlier studies have used lower than 1.5 
Tesla scanner for MRI scan of the brain 
(0.5 Tesla in the study by McCreadie et al 
2002 and 1.0 Tesla in the study by Chakos 
et al 1994). Interestingly, these two studies 
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did not find any difference in caudate 
volume. 
The slice thickness used in this study was 
one mm. Very few studies have used such 
a thin MR1 slice. The resolution of the 
image is affected by section thickness. The 
thinner the slice better will be the image 
resolution. The thicker the slice, the more 
likely that voxels will manifest partial vol-
ume effects, rather than be fully volumed 
(Lim et al 1995). Use of thin sections 
minimizes the error of estimating volume 
over multiple sections (Filipek et al 1989). 
Thus the importance of using thin sections 
cannot be overestimated for accurate vol-
ume measurement (Free et al 1995). 
The image analysis was done using coded 
MRI sections. The rater was blind to the 
clinical status of the subject. Measurements 
were done using computerized semi-auto-
mated software. These ensured elimination 
of rater bias. 
The brain area measurements were done 
under the supervision of a senior 
neuroradiologist (PNJ). The semi-auto-
mated Scion Image software provides valid 
and reliable measurements of specific struc-
tures using a semi automated segmentation 
approach (Keshavan et al 1995). Good 
inter-rater reliability was established with a 
senior neuroradiologist for morphometric 
ratings. This ensured reliable brain meas-
urements. 
There is inter-individual variation in the 
size of the brain. To control for this 
variation several methods have been de-
scribed. Use of intracranial area instead of 
intracranial volume may be seen as a limiting 
factor. But, it has been shown that the 
correction process using intracranial volume 
as well as intracranial area in the midsagittal 
section helps in the reduction of variance 
of volumetric measures of brain structures 
(Free et al 1995). Few of the previous 
studies have used brain ratio measurements 
to correct for the brain size variations. 
However, Harvey et al (1990) have recom-
mended a statistical correction using brain 
size as a covariate being superior to a ratio 
measure while controlling for brain size 
variations. In this study. Analysis of 
Covariance (ANCOVA) statistic was done 
using intracranial area as a covariate. This 
statistical correction avoided the confound-
ing effect of inter-individual brain size 
variations. 
Compared to the prior studies, our study 
has smaller sample size. However, even 
with this smaller sample size difference in 
caudate volume was detected by our study. 
Our observation of caudate volume reduc-
tion in never-treated schizophrenia may 
reflect primary pathophysiology of schizo-
phrenia. Recent studies have shown that 
the caudate nucleus is activated during 
working memory-related tasks (Monchi et al 
2001). Thus, caudate may be a part of a 
distributed neuronal network subserving 
functions associated with the dorsolateral 
prefrontal cortex (Keshavan et al 1998). 
Significandy reduced basal ganglia metabo-
lism has been observed in unmedicated 
schizophrenia patients through use of posi-
tron emission tomography (Weisel et al 
1987; Buchsbaum et al 1992; Siegel et al 
1993) and single photon emission tomog-
raphy (Vita et al 1995). Thus, this study 
finding is also consistent with functional 
neuroimaging research in schizophrenia. 
Despite the wide range of illness dura-
tion in the patient sample, no significant 
correlation was found between caudate 
volumes and illness duration. This finding 
of lack of association between caudate 
volume and illness duration & the obser-
vation of caudate volume reduction in 
never-treated schizophrenia provide some 
indirect support for neurodevelopmentaUy-
mediated pathology in schizophrenia 
(Weinberger, 1987). An exaggeration of 
periadolescent synaptic pruning, perhaps in 
glutamatergic corticosubcortical neurons, may 
be involved (Keshavan et al 1994). Reduced 
activity in these corticostriatal neurons, by 
diminishing trophic effects on the striatum, 
could conceivably lead to reduced synaptic 
neurophil, and thereby reduced size of basal 
ganglia; this view is consistent with a recent 
observation of reduced striatal dendritic 
spine size in postmortem brains of schizo-
phrenia patients (Roberts et al 1996). 
In summary, this study aimed to examine 
whether there is an independent underlying 
structural abnormality of caudate nucleus in 
never-treated schizophrenia. Though the 
small sample size and use of intracranial 
area instead of intracranial volume as 
covariate may make one derive cautious 
interpretations, the study is methodologi-
cally rigorous owing to the following rea-
sons: 
1. Patients were never-treated, 
2. All subjects were right handed, 
3. SCAN interview for establishing the 
diagnosis, 
4. Confirmation of diagnosis by two 
experienced psychiatrists, 
5. Stability of diagnosis in all patients at 
1-year follow-up as re-assessed by one 
of the two experienced psychiatrists, 
6. MRI slices were of 1 mm thickness, 
7. Ratings of brain measurements were 
done in coded MRI sections making 
the rater blind to clinical data, 
8. Good inter-rater reliability for brain 
measurements, 
9. Use of covariate rather than a ratio 
measure to correct for brain size 
variations. 
Thus, this research rigor matches with 
contemporary caudate imaging studies in 
schizophrenia. 
In conclusion, we have found signifi-
cantly smaller caudate volume in never-
treated schizophrenia. In addition there was 
no significant correlation between caudate 
volume and illness duration. These findings 
suggest neurodevelopmental etiopatfiogenesis 
in schizophrenia. 
REFERENCES 
American Psychiatric Association (1994). 
DSM-IV: Diagnostic and Statistical Manual of 
Mental Disorders. 4* ed., American Psychiatric 
Association, Washington, DC. 
Annett, M. The binomial distribution of 
right, mixed and left-handedness. (1967) 
Quarterly Journal of Experimental Psychology, 19, 
327-333. 
Breier, A., Buchanan, R.W., Elkshef, A., 
Munson, R.C., Kiricpatrick, B., Gellad, F. 
(1992) Brain morphology in schizophrenia. A 
magnetic resonance imaging study of limbic, 
prefrontal cortex and caudate structures. Arch 
Gen Psychiatry. 49, 291-926. 
<2<) REDUCED CAUDATE VOLUME IN SCHIZOPHRENIA 
Brown, K.W.,Wardlaw,J.M.,White,T, Walker, 
N.C. (1996) Caudate nucleus area in drug-
induced parkinsonism. Acta Psychiatr Scand, 94, 
348 - 351. 
Buchanan, R.W., Breier, A., Kirkpatrick, B., 
Elkashef, A., Munson, R.C., Gellad, F., Car-
penter, W.T. (1993) Structural abnormalities in 
i deficit and nondeficit schizophrenia. Am J 
J Psychiatry, 150, 59-65. 
Buchsbaum, M.S., Porkin, S.G., Siegel, B.V. 
Jr., Lohr, J., Katz, M., Gottschalk, L.A., 
Gulasekaram, B., Marshall, J.F., Lottenberg, 
S., Teng, C.Y. (1992) Striatal metabolic rate 
and clinical response to neuroleptics in schizo-
phrenia. Archives of General Psychiatry, 49, 966 
- 974. 
Busatto, G.F., Kerwin, R.W. (1997) Schizo-
phrenia, psychosis, and the basal ganglia. Psychia-
try Clinics of North America, 20, 897-910. 
Chakos, M.H., Lieberman, J.A., Alvir, J., 
Bilder, R., Ashtari, M. (1995). Caudate nuclei 
volumes in patients treated with typical 
antipsychotics or clozapine (letter). Lancet, 345, 
456-457. 
Chakos, M.H., Lieberman, J.A., Bilder, R.M., 
Borenstein, M., Lerner, G. (1994) Increase in 
caudate nuclei volumes of first-episode schizo-
phrenic patients taking antipsychotic drugs. 
American Journal of Psychiatry, 151, 1430 -
1436. 
• Corey-Bloom, J., Jernigan, T., Archibald, S., 
Harris, M.J., Jeste, D.V. (I99S) Quantitative 
magnetic resonance imaging of the brain in late-
life schizophrenia. American Journal of Psychia-
try, 152, 447 - 449. 
Corson, P.W., Nopoulos, P., Andreasen, N.C, 
Heckel, D., Arndt, S. (1999) Caudate size in 
first-episode Neuroleptic-nai've schizophrenic 
patients measured using an artificial neural 
network. Biol Psychiatry, 46, 712 - 720. 
Dalgalarrondo, P., Gattaz, W.F. (1994) Basal 
ganglia abnormalities in tardive dyskinesia: pos-
sible relationship with duration of neuroleptic 
treatment. Eur Arch Psychiatry Clin Neuro-
science, 244, 272 - 277. 
DeLisi, L.E., Hoff.A.L., Schwartz, J.E., Shields, 
G.W., Halthore, S.N., Gupta, S.M., Henn, 
F.A., Anand, A.K. (1991) Brain morphology in 
first-episode schizophrenia-like psychotic patients: 
a quantitative magnetic resonance imaging study. 
| Biological Psychiatry, 29, 159 - 175. 
Elkashef, AM., Buchanan, R.W., Gellad, F., 
Munson, R.C., Breier, A. (1994) Basal ganglia 
in schizophrenia and tardive dyskinesia: An MRI 
quantitative study. Am J Psychiatry, 151(5), 752 
- 755. 
Filipek, PA., Kennedy, D.N., Cayiness, V.S., 
Rossnick, S.L., Spraggins, T.A., Starewicz, 
P.M. (1989) Magnetic resonance imaging-based 
brain morphometry. Development and applica-
tion to normal subjects. Annals of Neurology, 
25, 61- 67. 
Flaum, M., Swayze V.W.I.I., O'Leary, D.S., Yuh, 
W.T.C., Ehrhardt, J.C., Arndt, S.V.,Andreasen, 
N.C. (1995) Effects of diagnosis, laterality, and 
gender on brain imaging morphology in schizo-
phrenia. Am J Psychiatry, 152, 704 - 714. 
Frazier, J .A., Gied, J.N., Kaysen, D., Albus, K., 
Hamburger, S., Alaghband-Rad, J. (1996) 
Childhood onset schizophrenia: Brain MRI rescan 
after 2 years of clozapine maintenance therapy. 
American Journal of Psychiatry, 153, 564 - 566. 
Free, S.L., Bergin, P.S., Fish, D.R., Cook, M.J., 
Shorvon, S.D., Stevens, J.M. (1995) Methods 
for normalization of hippocampal volumes meas-
ured with MR. Am J Neuroradiology, 16, 637-
643. 
Goldberg, D.P., Gater, R., Sartorius, N. (1997) 
The validity of two versions of the GHQ in the 
WHO study of mental illness in general health 
care. Psychological Medicine, 27(1), 191-7. 
Graybiel, A.M. (1997) The basal ganglia and 
cognitive pattern generators: Schizophr Bulletin, 
23(3), 459-469. 
Gur, R.E., Maany, V., Mozley, P.D., Swanson, 
C, Bilker, W., Gur, R.C. (1998) Subcortical 
MRI volumes in neuroleptic naive and treated 
patients with schizophrenia. American Journal of 
Psychiatry, 155, 1711 - 1717. 
Guy, W. (1976) Abnormal Involuntary Move-
ments Scale (AIMS). ECDEU Assessment Manual 
for Pharmacology. Rockville, Md: US Dept of 
Health, Education, and Welfare, 534-537. 
Harvey, I., Williams, M., Toone, B.K., Lewis, 
S.W., Turner, S., McGuffin, P. (1990) The 
ventricular-brain ratio in functional psychosis: the 
relationship of lateral ventricular and total in-
tracranial area. Psychological Medicine, 20, 55 -
62. 
Heckers, S., Heinsen, H., Heinsen, Y., 
Beckmann, H. (1991) Cortex, white matter 
and basal ganglia in schizophrenia: A volumetric 
postmortem study. Biological Psychiatry, 29, 556-
566. 
Heckers, S. (1997). Neuropathology of schizo-
phrenia: cortex, Thalamus, Basal ganglia and 
neurotransmitter-specific projection systems. 
Schizophrenia Bulletin, 23, 403-421. 
Hokama, H., Shenton, M.E., Nestor, P.G., 
Kikinis, R., Levitt, J.J., Metcalf, D. (1995) 
Caudate, Putamen and globus pallidus volume in 
schizophrenia: A quantitative MRI study. Psychia-
try Research Neuroimaging, 61, 209-229. 
Jernigan, T.L., Zisook, S., Heaton, R.K., 
Moranville, J.K., Hesselink, J.R., Braff, D.L. 
(1991) Magnetic resonance imaging abnormali-
ties in lenticular nuclei and cerebral cortex in 
schizophrenia. Archives General Psychiatry, 48, 
881-890. 
Kay, S.R., Fizbein, A., Opler, A. (1987) The 
Positive and Negative Syndrome Scale (PANSS) 
for schizophrenia. Schizophrenia Bulletin, 2, 261-
276. 
Kelsoe, J.R. Jr, Cadet, J.L., Pickar, D., 
Weinberger, D.R. (1988) Quantitative neuro-
anatomy in schizophrenia: a controlled magnetic 
resonance imaging study. Archives of General 
Psychiatry, 45. 533 - 541. 
Keshavan, M.S., Anderson, S., Beckwith, C, 
Nash, K., Pettergrew, J., Krishnan K.R.R. 
(1995) A comparison of stereology and segmen-
tation techniques for volumetric measurements 
of brain ventricles. Psychiatric Research 
Neuroimaging, 61, 53-60. 
Keshavan, M.S., Anderson, S., Pettergrew, 
J.W. (1994) Is schizophrenia due to excessive 
synaptic pruning in the prefrontal cortex? the 
Feinberg hypothesis revisited. Journal of Psychi-
atric Research, 28, 239-245. 
Keshavan, M.S., Diwadkar, V.A., Bagwell, 
W.W., Harenski, K., Rosenberg, D.R., 
Sweeney, J.A., Pettergrew, J.W. (2002) Ab-
normalities of Corpus Callosum in first episode 
treatment naive schizophrenia. Journal of Neu-
rology, Neurosurgery, Psychiatry, 72(6):757-60. 
Keshavan, M.S., Rosenberg, D., Sweeney, 
J.A., Petergrew, J.W. (1998) Decreased cau-
date volume in neuroleptic-naive psychotic pa-
tients. Am J Psychiatry, 155, 774 - 778. 
Kraepelin E. Dementia Praecox and Para-
phrenia (1919). Translated by ed. Barclay RM, 
Robertson GM. New York: Robert E Kreiger, 
1971:77 - 83. 
Levy, R., Friedman, H.R., Davachl, L., 
Goldman-Rakic, P.S. (1997) Differential acti-
vation of the caudate nucleus in primates per-
forming spatial and non spatial working memory 
tasks. Journal of Neuroscience 17. 3870-3882. 
Lim, K.O., Rosenbloom, M., Pfenerbaum, A. 
(1995) In vitro structural brain assessment. In 
Psychopharmacology - The Fourth Generation of 
Progress, Eds. Bloom, F.E., Kupfer, D.J. Raven Press, 
Ltd., New York , 881 - 894. 
McCreadie, R.G., Thara, R., Padmavathi, R., 
Srinivasan, T.N., Jaipurkar, S.D. (2002) Struc-
tural brain differences between never-treated 
patients with schizophrenia, with and without 
dyskinesia, and normal control subjects. A mag-
netic resonance imaging study. Arch Gen Psy-
chiatry, 59, 332-336. 
MkkJIeton, RA., Stride, P.L (1994) Anatomical 
(25) VENKATASUBRAMANIAN at ml 
evidence for cerebellar and basal ganglia involve-
ment in higher cognitive function. Science, 266, 
458-461. 
Mion, C.C., Andreasen, N.C., Arndt, S., 
Swayze, V.W.I.I., Cohen, G.A. (1991) MRI 
abnormalities in tardive dyskinesia. Psychiatry 
Research. 40. 157 - 166. 
Monchi, O., Petrides, M.t Petre, V., Worsley, 
K., Dagher, A. (2001) Wisconsin Card Sorting 
revisited: distinct neural circuits participating in 
different stages of the task identified by event-
related functional magnetic resonance imaging. 
Journal of Neurosciences, 21(19), 7733-41. 
Ring, H.A., Serra-Mestres, J. (2002) Neu-
ropsychiatry of the basal ganglia. J Neurol 
Neurosurg Psychiatry, 72, 12 - 21. 
Roberts, R.C., Conley, R., Rung, L, Peretti, 
F.J., Chute, D.J. (1996) Reduced striatal spine 
size in schizophrenia: a postmortem ultrastruc-
tural study. Neuroreport, 7, 1214-1218. 
Rodriguez, R., Flaum, M., Nopoulos, P. (1997) 
The effect of cumulative Neuroleptic exposure 
on caudate and putamen volume (abstract). 
Schizophrenia Research 24, 154 - 155. 
Shenton, M.E.,Wible, C.G.. McCarley, R.W. 
(1997) A review of magnetic resonance imaging 
studies of brain abnormalities in schizophrenia, 
In brain imaging in child psychiatry. Edited by 
Krishnana KRR, Doraiswamy PM, New York, 
Marcel Dekker. pp 297-380. 
Shihabuddln, L, Buchsbaum, M„ HazJett, 
E.A., Haznedar, M.M., Harvey, P.D., Newman, 
A. (1998). Dorsal striatal size, shape, and 
metabolic rate in never-medicated and previously 
medicated schizophrenics performing a verbal 
learning task. Archives of General Psychiatry, 
55, 235 - 243. 
Siegel, B.V., Buchsbaum, M.S., Bunney, W.F., 
Gottschalk, L.A., Haier, R.J., Lohr, J.B., 
Lottenberg, S., Najafi, A. (1993) Cortical-
striatal-thalamic circuits and brain glucose meta-
bolic activity in 70 unmedicated male schizo-
phrenic patients. American Journal of Psychiatry, 
150, 1325-1336. 
Simpson, G.M., Angus, J.W.S. (1970) A rating 
scale for extrapyramidal side effects. Acta Psychiatr 
Scand Suppl.. 212, 11-19. 
Swayze, V.W.I.I., Andreasen, N.C., Alliger, 
RJ.,Yuh, W.T., Ehrhardt, J.C. (1992) Subcor-
tical and temporal structures in affective disorder 
and schizophrenia: A magnetic resonance imaging 
study. Biological Psychiatry, 3, 221- 240. 
Vita, A., Bressi, S., Perani, D., Invernizzi, G., 
Giobbio, G.M., Died, M., Garbarini, M., Del 
Sole, A., Fazio, F. (1995) High-resolution SPECT 
study of regional cerebral blood flow in drug-
free and drug-naive schizophrenic patients. 
American Journal of Psychiaty, 152, 876-882. 
Walker, E., Lewin, R.J. (1990) Predictions of 
adult-onset schizophrenia from childhood home 
movies of the patients. Am J Psychiatry, 147, 
1052-1056. 
Watkins, K.E., Paus,T., Lerch, j.R, Zijdenbos, 
A., Collins, D.L., Neelin, P„Taykw, J., Worsley, 
K.J., Evans, A.C. (2001) Structural asymmetries 
in the human brain: a voxel-based statistical 
analysis of 142 MRI scans. Cerebral Cortex, 
11(9), 868-77. 
Weinberger, D.R. (1987) Implications of nor-
mal brain development for the pathogenesis of 
schizophrenia. Arch Gen Psychiatry, 44, 660-669. 
Weisel, F.A., Wilk, G., Sjogren, J., Blomquist, 
G., Greitz, T. (1987) Altered relationships 
between metabolic rates of glucose in brain 
regions of schizophrenic patients. Acta Psychiatrica 
Scandinavica, 76, 642-647. 
Westermoreland Corson, P., Nopoulos, P., 
Arndt, S.V., Miller, D„ Andreasen, N.C. 
(1999) Change in basal ganglia volume over 2 
years in patients with schizophrenia: typical 
versus atypical neuroleptics. American Journal of 
Psychiatry, 156(8), 1200-4. 
Woodruff, P., Pearson, G., Geer, M., Barta, 
P., Childoat, H. (1993) A computerized 
magnetic resonance imaging study of corpus 
callosum morphology in schizophrenia. Psycho-
logical Medicine, 23, 45 - 56. 
World Health Organization (1998). Sched-
ules for Clinical Assessment in Neuropsychiatry 
(version 2.1). World Health Organization, Ge-
neva. 
Young, A.H., Blackwood, D.H., Roxborough, 
H., McQueen, J.K., Martin, M.J., Kean, D. 
(1991) A magnetic resonance imaging study of 
schizophrenia: brain structure and clinical symp-
toms. British Journal of Psychiatry, 158, 158 -
164. 
•GANESAN VENKATASUBRAMANIAN'. B.N. GANGADHAR
1, P.N. JAYAKUMAR
2. N JANAKIRAMAIAH
1, M. S. KESHAVAN
3 
1 Department Of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India. 
2 Department of Neuroimaging and Interventional Radiology, National Institute of Mental Health and Neurosciences, Bangalore, India. 
3 Western Psychiatric Institute and Clinic, 3811 O'Hara Street, Pittsburgh, PA 15213-2593 
'Correspondence 
E-Mail: maniangvs@yahoo.com 
Acknowledgement: This work was supported by Indo-US project I R43 04370-01AI 1997-2001. 
(26) 